Centene Corporation
Centene Corp. is a U.S. managed care company built around government-sponsored and underserved populations, with a mission centered on Medicaid, Medicare, and Marketplace members. It operates state-based health plans and local brands that are designed to work closely with providers, policymakers, and community organizations. The company also has adjacent businesses in specialty pharmacy and behavioral health, which broaden its care-management footprint. Centene’s model depends on winning and retaining public and commercial contracts while managing medical cost trends, regulatory requirements, and local market execution.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueState Medicaid managed care plans for low-income and underserved members.
Medicare Advantage and Medicare Part D plans for seniors and eligible members.
Marketplace and other commercial individual/family health plans, including ICHRA-compatible offerings.
Specialty pharmacy, behavioral health, and related services businesses.
Products
Reported · share of revenue- Health Care Premium98.3 %
- Services1.7 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Centene’s core customers are state Medicaid agencies and other public payers that award managed care contracts based on quality, network access, administrative performance, and local market presence. A second major customer group is Medicare members, including beneficiaries using Medicare Advantage and Medicare Prescription Drug Plans, where plan quality, supplemental benefits, and provider access drive enrollment. The company also serves individuals and families buying coverage through the Health Insurance Marketplace, including off-exchange products designed for ICHRA adoption. In its Other segment, Centene sells specialty pharmacy and behavioral health services to health plans, employers, unions, government agencies, and third-party administrators. Across these segments, the buying decision is driven by affordability, network breadth, service quality, and the ability to manage care and outcomes for complex populations.
Buy managed care coverage and administration because Centene can serve large, complex, low-income populations under state contracts.
Buy Medicare Advantage and Part D plans for coverage, supplemental benefits, and network access.
Buy individual health plans for affordability and access, including ICHRA-compatible offerings.
Buy off-exchange plans to give employees more choice and predictable premiums.
Buy outsourced care management, pharmacy distribution, and behavioral health services to improve access and outcomes.
Strategy
Centene’s near-term strategy is to improve productivity, reduce organizational costs, and deploy capital through stock repurchases, portfolio optimization, and refinancing opportunities. The company is also focused on strengthening member and provider experience, which is important because contract awards and retention depend on quality, network access, and service performance. In its growth businesses, Centene is expanding Medicare and Marketplace offerings, including ICHRA-compatible plans, to capture a broader commercial addressable market. The company is also managing its portfolio by exiting non-core assets, including the planned divestiture of remaining Magellan Health businesses, while preserving scale in core managed care. Liquidity, dividend capacity from subsidiaries, and access to the revolving credit facility remain important to support operations and capital deployment.
Lower administrative cost and better operating efficiency support margins in a regulated, price-sensitive business.
Diversifies the revenue base beyond Medicaid and captures demand from seniors and individual buyers.
Focuses capital and management attention on core managed care while reducing complexity.
Supports shareholder returns and funding needs while preserving liquidity under regulatory constraints.
Geography
Centene’s business is overwhelmingly U.S.-centric, with operations organized around state-based health plans and contracts with U.S. federal and state agencies. Geography matters because Medicaid and many other programs are regulated and funded at the state level, so local market execution, provider networks, and state-specific rate setting are central to performance. The company’s local-brand model is designed to adapt to different state rules and competitive conditions rather than rely on a single national product. Its exposure is therefore tied to U.S. policy changes, state contract renewals, and regional differences in healthcare utilization and reimbursement. The reports provided do not disclose a country-level revenue split, so no country breakdown is available from the excerpted materials.
Risks
Centene’s largest business risk is medical cost trend and rate adequacy: if utilization or acuity rises faster than state and CMS reimbursement, margins and cash flow can deteriorate quickly. Because the company relies on third-party vendors, claims systems, and data infrastructure, operational failures or cyber incidents could disrupt service delivery and expose sensitive health information. Regulatory and contract risk is also material, since Medicaid and Medicare businesses depend on state and federal rules, minimum medical loss ratio requirements, and performance metrics that can trigger premium refunds or limit revenue recognition. Competitive pressure from other managed care organizations, provider consolidation, and new entrants can reduce membership growth and pricing flexibility. The company also faces impairment and integration risk from acquisitions and portfolio changes, as shown by the large goodwill impairment in 2025 and the planned divestiture of Magellan businesses.
- Medical cost trend and rate adequacyImpact: HighLikelihood: High
If medical utilization, acuity, or pharmacy costs rise faster than reimbursement, Centene may not recover its claims costs.
Exposure - Regulatory and contract complianceImpact: HighLikelihood: High
State and CMS contracts can require minimum MLRs, quality metrics, and premium refunds, directly affecting revenue and earnings.
Exposure: Government-sponsored health plans
- Goodwill and intangible asset impairmentImpact: HighLikelihood: High
The company recorded a large goodwill impairment in 2025, showing that valuation assumptions can change materially.
Exposure: Reporting units and acquired businesses
- Cybersecurity and systems disruptionImpact: HighLikelihood: Medium
Claims processing and member data depend on secure IT systems and vendors, so breaches or outages can create service and legal costs.
Exposure: Enterprise systems and third-party vendors
- Competitive pressure and industry consolidationImpact: MediumLikelihood: Medium
Stronger rivals or provider consolidation can reduce Centene’s ability to win contracts, retain members, and control medical costs.
Exposure: Managed care markets
Accounting
Judgemental itemsEstimates for incurred but not reported claims and utilization trends directly affect reported earnings and reserve adequacy.
Impact: Can materially change quarterly medical cost ratios and operating income.
Premium revenue is based on state/CMS membership data that is updated retroactively, creating timing differences and estimate revisions.
Impact: Can cause revenue volatility and prior-period adjustments.
Required refunds or deferred revenue recognition reduce current-period revenue when thresholds are not met or not yet measurable.
Impact: Affects premium revenue and margin comparability.
Valuation depends on forecast cash flows, discount rates, and regulatory capital assumptions; Centene recorded a large impairment in 2025.
Impact: Can create large non-cash charges and signal weaker long-term expectations.
Insurance subsidiaries face statutory surplus requirements that limit upstream cash transfers.
Impact: Affects liquidity, capital allocation, and debt service flexibility.
Similar listed companies
Publicly listed companies with a comparable business focus.
Centessa Pharmaceuticals plc
Pharmaceutical Preparations
Centessa Pharmaceuticals plc is a clinical-stage biopharmaceutical company built around an asset-centric model, where each program is developed with its own…
Cigna Group
CI · Hospital & Medical Service Plans
Cigna Group is a U.S.-based global health company that combines health benefits and pharmacy/medical services through two core segments: Cigna Healthcare and Evernorth Health Services.
Cencora, Inc.
COR · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cencora is a pharmaceutical sourcing and distribution company that sits between drug manufacturers and healthcare providers, moving branded, specialty,…
Prestige Consumer Healthcare Inc.
PBH · Pharmaceutical Preparations
Accendra Health, Inc
ACH · Wholesale-Medical, Dental & Hospital Equipment & Supplies
GoHealth, Inc.
Insurance Agents, Brokers & Service
Last updated: 24/09/2026